Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,047
Total Claims
$845K
Drug Cost
553
Beneficiaries
$1,529
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-78%
Opioid rate vs peers
0.6% vs 2.6% avg
+43%
Cost per patient vs peers
$1,529 vs $1,068 avg
+17%
Brand preference vs peers
10.5% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
0.6%
Opioid Rate
57
Opioid Claims
$394
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,053 claims · $696K
Generic: 8,947 claims · $148K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dulaglutide | 140 | $178K |
| Apixaban | 86 | $89K |
| Tirzepatide | 66 | $84K |
| Empagliflozin | 64 | $66K |
| Semaglutide | 42 | $43K |
| Rivaroxaban | 31 | $38K |
| Dapagliflozin Propanediol | 27 | $27K |
| Insulin Glargine,hum.Rec.Anlog | 24 | $27K |
| Insulin Glargine,hum.Rec.Anlog | 28 | $25K |
| Mirabegron | 23 | $19K |
| Sitagliptin Phosphate | 14 | $12K |
| Bempedoic Acid/Ezetimibe | 14 | $7,701 |
| Atorvastatin Calcium | 479 | $6,372 |
| Rosuvastatin Calcium | 278 | $5,612 |
| Losartan Potassium | 440 | $5,198 |
Prescribing Profile
Patient Profile
73
Avg Age
53%
Female
1.07
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About